Journal
FUTURE ONCOLOGY
Volume 17, Issue 3, Pages 301-313Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2020-0022
Keywords
colorectal cancer; differentially expressed genes; 7-gene prognostic model; The Cancer Genome Atlas
Categories
Funding
- Henan innovative scientific and technological talents team construction project [192101510001]
Ask authors/readers for more resources
Traditional screening and therapeutic programs for colorectal cancer are insufficient, but advances in immunogenomics show promise. By identifying survival-related IRGs and establishing a prognostic model, it offers a new approach in determining risk for CRC patients.
Screening and therapeutic programs for colorectal cancer (CRC) are invasive or not effective and unable to meet patient needs. Major advances in immunogenomics may change this status but need more exploration. Differentially expressed genes and immune-related genes (IRGs) were identified by computational methods. A prognostic model was established and validated based on survival-related IRGs via stepwise multivariate Cox regression analysis. Nine IRGs were selected and identified as survival-related genes. A 7-gene prognostic model could offer a preliminary and valid determination of risk in CRC patients. The area under the curve of the receiver operating characteristic was 0.672. The 7-gene prognostic model might be used as a novel prognostic tool in CRC patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available